Jonathan Lopez

4.3k total citations · 2 hit papers
89 papers, 2.7k citations indexed

About

Jonathan Lopez is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Jonathan Lopez has authored 89 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 28 papers in Oncology and 22 papers in Surgery. Recurrent topics in Jonathan Lopez's work include Thyroid Cancer Diagnosis and Treatment (14 papers), Cell death mechanisms and regulation (13 papers) and Cancer Genomics and Diagnostics (7 papers). Jonathan Lopez is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (14 papers), Cell death mechanisms and regulation (13 papers) and Cancer Genomics and Diagnostics (7 papers). Jonathan Lopez collaborates with scholars based in France, United States and United Kingdom. Jonathan Lopez's co-authors include Stephen W. G. Tait, Joel S. Riley, Andrew Oberst, Françoise Descôtes, Kevin M. Ryan, Jim O’Prey, Germain Gillet, Myriam Decaussin‐Petrucci, Ann P. Wheeler and Catherine Cloix and has published in prestigious journals such as Circulation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jonathan Lopez

86 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial apoptosis: killing cancer using the enemy within

2015 606 citations Jonathan Lopez, Stephen W. G. Tait profile →
Mitochondrial inner membrane permeabilisation enables mt DNA release during apoptosis

2018 393 citations Joel S. Riley, Giovanni Quarato et al. The EMBO Journal profile →

Peers

Countries citing papers authored by Jonathan Lopez

Since Specialization

Citations

This map shows the geographic impact of Jonathan Lopez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Lopez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Lopez more than expected).

Fields of papers citing papers by Jonathan Lopez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Lopez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Lopez. The network helps show where Jonathan Lopez may publish in the future.

Co-authorship network of co-authors of Jonathan Lopez

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Lopez. A scholar is included among the top collaborators of Jonathan Lopez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Lopez. Jonathan Lopez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	From hyperplasia to carcinoma: a molecular driven adrenal disease 2025 ·European Journal of Endocrinology ·(unknown), Myriam Decaussin‐Petrucci, Françoise Descôtes, Gérald Raverot, Jean‐Christophe Lifante, Christophe Sajous, Jonathan Lopez, Hélène Lasolle	0
2	Molecular Relationship Between Ovarian Sertoli-Leydig Cell Tumors and Their Heterologous Elements 2025 ·The American Journal of Surgical Pathology ·(unknown), (unknown), Françoise Descôtes, Jonathan Lopez, Isabelle Treilleux, Gerlinde Avérous, (unknown), (unknown), Delphine Loussouarn, Frédérique Dijoud, Isabelle Ray‐Coquard, Benoît You, Eudéline Alix, (unknown), Catherine Genestie, (unknown)	0
3	ZEB1 transcription factor induces tumor cell PD-L1 expression in melanoma 2025 ·Cancer Immunology Immunotherapy ·(unknown), Simon Durand, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), B. Balme, (unknown), (unknown), Stéphane Dalle, Jonathan Lopez, Julie Caramel	1
4	Clinically aggressive follicular cell-derived thyroid carcinoma: A comprehensive series with histomolecular characterization and discovery of novel gene fusions 2024 ·Human Pathology ·(unknown), Françoise Descôtes, Jonathan Lopez, (unknown), Françoise Borson‐Chazot, Jean‐Christophe Lifante, Myriam Decaussin‐Petrucci	2
5	Peculiar nuclear atypia associated with MDM2 gene amplification in carcinoma ex‐pleomorphic adenoma harbouring an alteration of HMGA2 2024 ·Histopathology ·(unknown), M. Fieux, Françoise Descôtes, Jonathan Lopez, (unknown), (unknown), (unknown), Daniel Pissaloux, Philippe Céruse, (unknown), Nazim Benzerdjeb	3
6	Primary Vulvar and Vaginal Adenocarcinomas of Intestinal Type Are Closer To Colorectal Adenocarcinomas Than To Carcinomas of Müllerian Origin 2024 ·Modern Pathology ·Alexis Trécourt, Isabelle Treilleux, Daniel Pissaloux, (unknown), (unknown), (unknown), Aurélie Houlier, Sandrine Paindavoine, (unknown), (unknown), (unknown), Pierre‐Adrien Bolze, Paulette Chaix, (unknown), Françoise Descôtes, Isabelle Ray‐Coquard, Jonathan Lopez, Mojgan Devouassoux‐Shisheboran	3
7	Molecular Analyses of Chorionic-Type Intermediate Trophoblastic Lesions: Atypical Placental Site Nodules are Closer to Placental Site Nodules Than Epithelioid Trophoblastic Tumors 2023 ·Modern Pathology ·(unknown), Fabienne Allias, Alexis Trécourt, (unknown), Pierre‐Adrien Bolze, Françoise Descôtes, (unknown), (unknown), Touria Hajri, Benoît You, François Golfier, Jonathan Lopez, Mojgan Devouassoux‐Shisheboran	11
8	Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii 2023 ·Histopathology ·(unknown), Alexis Trécourt, Jonathan Lopez, (unknown), Françoise Descôtes, Françoise Borson‐Chazot, Isabelle Ray‐Coquard, Myriam Decaussin‐Petrucci, Mojgan Devouassoux‐Shisheboran	10
9	PARP Inhibitors: A Major Therapeutic Option in Endocrine-Receptor Positive Breast Cancers 2022 ·Cancers ·L. Collet, Julien Péron, Frédérique Penault‐Llorca, Pascal Pujol, Jonathan Lopez, Gilles Freyer, Benoît You	7
10	ZEB1 transcription factor promotes immune escape in melanoma 2022 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), (unknown), (unknown), Laurie Tonon, Jonathan Lopez, (unknown), B. Balme, (unknown), Arnaud de la Fouchardière, Lionel Larue, Alain Puisieux, Yenkel Grinberg‐Bleyer, Nathalie Bendriss‐Vermare, Bertrand Dubois, Christophe Caux, Stéphane Dalle, Julie Caramel	55
11	SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Role of molecular tests for cytologically indeterminate thyroid nodules 2022 ·Annales d Endocrinologie ·Hélène Lasolle, Jonathan Lopez, François Pattou, Françoise Borson‐Chazot, Stéphane Bardet, Lionel Groussin, Camille Buffet	7
12	The apoptosis inhibitor Bcl-xL controls breast cancer cell migration through mitochondria-dependent reactive oxygen species production 2020 ·Oncogene ·(unknown), Jonathan Lopez, Rudy Gadet, Mathieu Deygas, Nikolay Popgeorgiev, Delphine Poncet, (unknown), (unknown), Ivan Mikaélian, Philippe Gonzalo, Ruth Rimokh, Germain Gillet	44
13	Carcinome papillaire de la thyroïde à cellules en clous de tapissier 2020 ·Annales de Pathologie ·(unknown), Jonathan Lopez, J.C. Lifante, Myriam Decaussin‐Petrucci	1
14	The dynamic molecular landscape of malignant melanomas arising from congenital or common nevi 2019 ·Integrative Molecular Medicine ·(unknown), (unknown), Françoise Descôtes, B. Balme, L. Depaepe, Pierre‐Paul Bringuier, Julie Caramel, L. Thomas, Stéphane Dalle, Jonathan Lopez	1
15	Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10 2018 ·Cancer Research ·(unknown), Nikolay Popgeorgiev, Loay Kassem, Soleilmane Omarjee, (unknown), Ivan Mikaélian, Jonathan Lopez, Rudy Gadet, Olivier Marcillat, Isabelle Treilleux, Bruno O. Villoutreix, Ruth Rimokh, Germain Gillet	34
16	Mitochondrial inner membrane permeabilisation enables mt DNA release during apoptosis breakdown → 2018 ·The EMBO Journal ·Joel S. Riley, Giovanni Quarato, Catherine Cloix, Jonathan Lopez, Jim O’Prey, Matthew Pearson, James Chapman, Hiromi Sesaki, Leo M. Carlin, João F. Passos, Ann P. Wheeler, Andrew Oberst, Kevin M. Ryan, Stephen W. G. Tait	393
17	TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients 2015 ·BMC Cancer ·Loay Kassem, Mathieu Deygas, Laurent Fattet, Jonathan Lopez, (unknown), Emilie Lavergne, Sylvie Chabaud, Nicolas Carrabin, Nicolás Chopin, Thomas Bachelot, Germain Gillet, Isabelle Treilleux, Ruth Rimokh	32
18	Src tyrosine kinase inhibits apoptosis through the Erk1/2- dependent degradation of the death accelerator Bik 2012 ·Cell Death and Differentiation ·Jonathan Lopez, Cédric Hesling, Julien Prudent, Nikolay Popgeorgiev, Rudy Gadet, Ivan Mikaélian, Ruth Rimokh, Germain Gillet, Philippe Gonzalo	47
19	Lithium suppresses motility and invasivity of v-src-transformed cells by glutathione-dependent activation of phosphotyrosine phosphatases 2009 ·Oncogene ·(unknown), Jonathan Lopez, Anne Chabadel, Germain Gillet	9
20	Preservation of prostate during radical cystectomy: Evaluation of prevalence of prostate cancer associated with bladder cancer 2005 ·Urology ·A. Ruffion, Anne‐Marie Manel, W. Massoud, Myriam Decaussin, Nicole Berger, P. Paparel, N. Morel-Journel, Jonathan Lopez, (unknown), M. Devonec, Paul B. Perrin	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact